As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...

ResMed Chief Executive Mick Farrell usually delegates negotiations with suppliers to the San Diego company’s production executives. But amid continuing component shortages, Farrell has been on ...

ResMed stock was the worst performer in the S&P 500 Monday as Eli Lilly’s weight-loss medicine showed signs of reducing sleep apnea. Lilly said its medication tirzepatide, sold under the brand names ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

As Philips stares down an international recall of more than 2 million of its CPAP and sleep apnea machines, the respiratory devicemaker ResMed is looking to pick up the slack—but the surge in demand ...

For my first rating of ResMed, I'm calling a buy, agreeing with today's consensus from Wall St. and more confident than the quant system, which said hold. Key upside factors are new business ...